1.4000
-0.0100
(-0.71%)
As of 2:39:33 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 150k | 150k | 500k | 5M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 300k | 300k | 1M | 10M |
| Year Ago Sales | 196k | 196k | 743k | 500k |
| Sales Growth (year/est) | -23.47% | -23.47% | -32.71% | 900.00% |
Earnings History
| Currency in USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -1.9 | -0.73 | -0.43 | -0.37 |
| EPS Actual | 0 | 0 | 0 | -3 |
| Difference | 1.9 | 0.73 | 0.43 | -2.63 |
| Surprise % | 100.00% | 100.00% | 100.00% | -710.81% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CANF | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 3/21/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/20/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/18/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/3/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/18/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 12/31/2024 |
Related Tickers
APLIF Appili Therapeutics Inc.
0.0210
0.00%
BLRX BioLineRx Ltd.
2.4550
-9.07%
PLUR Pluri Inc.
3.7900
-4.29%
PPBT Purple Biotech Ltd
2.4500
-1.21%
OKYO OKYO Pharma Limited
1.0900
-0.91%
CNTB Connect Biopharma Holdings Limited
0.6075
-7.94%
LPCN Lipocine Inc.
3.1400
+2.61%
XTLB XTL Biopharmaceuticals Ltd.
1.1600
-1.69%
HOTH Hoth Therapeutics, Inc.
0.8003
-0.44%
BCLI Brainstorm Cell Therapeutics Inc.
0.8619
-24.39%